Recently, it was demonstrated that GW2580, another pharmacological inhibitor of CSF-1R, induced MHC-II expression, phagocytosis, and the T-cell-mediated killing of GBM tumors in patient-derived 3D organoid models [131]. Here, CSF1R is linked to glioblastoma.